Titan America SA Common Shares (TTAM)
13.25
-0.39 (-2.90%)
NYSE · Last Trade: Jun 12th, 3:49 PM EDT

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025